Anti-Human RANTES (CCL5) (Monoclonal Mouse) 0 评论Submit a Review 产品详情 产品编号: 500-M75 产品描述: Source: Monoclonal Mouse Preparation: Produced in BALB/c mice immunized with highly pure Recombinant Human RANTES (CCL5). Anti-Human RANTES (CCL5)-specific antibody was purified from ascites fluid by Protein A affinity chromatography. Immunogen: E.coli derived Recombinant Human RANTES (CCL5) (PeproTech catalog# 300-06) Sandwich ELISA: In a sandwich ELISA (assuming 100μl/well), a concentration of 2.0-4.0 μg/ml of this antibody will detect at least 500pg/ml of Recombinant Human RANTES when used with PeproTech’s Biotinylated Antigen Affinity Purified anti-Human RANTES (CCL5) (500-P36BT) as the detection antibody at a concentration of approximately 0.5-1.0 μg/ml. Western Blot: To detect Human RANTES by Western Blot analysis this antibody can be used at a concentration of 0.5-1.0 μg/ml. When used in conjunction with compatible secondary reagents the detection limit for Recombinant Human RANTES is 0.25-2.0 ng/lane, under reducing conditions and 0.25-0.5 ng/lane, under non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. crossreactivity: Human References SDS CoA 搜索 Product Line Country Of Origin: USA Not for human use. Research Interest 艾滋病/HIV 血管生成/心血管 化学趋化 免疫系统 炎症 神经生物学 创伤修复 过敏 移植 product.subtitle.recentcitations 第一作者 Soria, G 标题 Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition. 文献引用 BMC Cancer; 11 pg130 PubMed Id 21486440 第一作者 Yaal-Hahoshen, N 标题 The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. 文献引用 Clinical cancer research : an official journal of the American Association for Cancer Research; 12(15) pg4474-80 PubMed Id 16899591 第一作者 Azenshtein, E 标题 The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. 文献引用 Cancer Research; 62(4) pg1093-102 PubMed Id 11861388